Metabolic Activity Of Intestinal Bacteria Research Articles

Multi-kingdom microbiota and functions changes associated with culture mode in genetically improved farmed tilapia (Oreochromis niloticus).

Genetically improved farmed tilapia (GIFT, Oreochromis niloticus) are intensively farmed in China, where most of the yield derives from the pond culture system (PCS). The in-pond raceway system (IPRS) is a new type of highly efficient aquaculture mode, and has been recommended as a novel system for GIFT farming. To determine the effects of these culture modes on the gut microbiome of GIFT, we conducted a 90-days experiment in IPRS and PCS units. A 16S rRNA gene profile analysis showed that the composition of gut microbiota in GIFT under IPRS and PCS conditions gradually separated as rearing progressed, with divergent responses by the midgut and hindgut bacteria. The α-diversity in hindgut decreased significantly by day 90, as compared with on day 7 (p < 0.05), with a significantly greater decrease in PCS-reared fish than in IPRS fish (p < 0.05). The α-diversity of microbiota in midgut remained stable (p > 0.05). The overall dominant gut bacteria were Bacteroidetes, Proteobacteria, and Firmicutes. Rearing mode affected the taxonomic profile of the gut bacteria; in midgut, IPRS samples had more Firmicutes and Fusobacteria compared with PCS samples, but less Proteobacteria, Verrucomicrobia, and Actinobacteria. Firmicutes was enriched in IPRS hindgut, and Fusobacteria was enriched in PCS hindgut. Using random-forest models and LEfSe, we also screened core taxa that could discriminate between the gut microbial communities under IPRS and PCS conditions. The genus Cetobacterium (of family Fusobacteriaceae) was significantly enriched in midgut in IPRS fish, and enriched in hindgut in PCS fish. The genus Clostridium sensu stricto (of family Clostridiaceae 1) was significantly enriched in both IPRS midgut and hindgut. Analysis with PICRUSt2 software revealed that the culture modes were similar in their effects on the gut microbial metabolic functions. The predicted pathways were significantly enriched in the metabolism class (level 1). Further, the relative abundance of functions related to amino acid metabolic, carbohydrate metabolic, energy metabolic, and metabolic of cofactors and vitamins were high at hierarchy level 2, as the metabolic activity of intestinal bacteria is especially active. Overall, this study enhances our understanding of the characteristics of gut microbiota in GIFT under IPRS and PCS culture modes. Moreover, our findings provide insights into the microecological balance in IPRS units, and a theoretical reference for further development of this culture system.

Raman-deuterium isotope probing to study metabolic activities of single bacterial cells in human intestinal microbiota.

SummaryHuman intestinal microbiota is important to host health and is associated with various diseases. It is a challenge to identify the functions and metabolic activity of microorganisms at the single‐cell level in gut microbial community. In this study, we applied Raman microspectroscopy and deuterium isotope probing (Raman–DIP) to quantitatively measure the metabolic activities of intestinal bacteria from two individuals and analysed lipids and phenylalanine metabolic pathways of functional microorganisms in situ. After anaerobically incubating the human faeces with heavy water (D2O), D2O with specific substrates (glucose, tyrosine, tryptophan and oleic acid) and deuterated glucose, the C–D band in single‐cell Raman spectra appeared in some bacteria in faeces, due to the Raman shift from the C–H band. Such Raman shift was used to indicate the general metabolic activity and the activities in response to the specific substrates. In the two individuals' intestinal microbiota, the structures of the microbial communities were different and the general metabolic activities were 76 ± 1.0% and 30 ± 2.0%. We found that glucose, but not tyrosine, tryptophan and oleic acid, significantly stimulated metabolic activity of the intestinal bacteria. We also demonstrated that the bacteria within microbiota preferably used glucose to synthesize fatty acids in faeces environment, whilst they used glucose to synthesize phenylalanine in laboratory growth environment (e.g. LB medium). Our work provides a useful approach for investigating the metabolic activity in situ and revealing different pathways of human intestinal microbiota at the single‐cell level.

Differences in gluten metabolism among healthy volunteers, coeliac disease patients and first-degree relatives.

Coeliac disease (CD) is an immune-mediated enteropathy resulting from exposure to gluten in genetically predisposed individuals. Gluten proteins are partially digested by human proteases generating immunogenic peptides that cause inflammation in patients carrying HLA-DQ2 and DQ8 genes. Although intestinal dysbiosis has been associated with patients with CD, bacterial metabolism of gluten has not been studied in depth thus far. The aim of this study was to analyse the metabolic activity of intestinal bacteria associated with gluten intake in healthy individuals, CD patients and first-degree relatives of CD patients. Faecal samples belonging to twenty-two untreated CD patients, twenty treated CD patients, sixteen healthy volunteers on normal diet, eleven healthy volunteers on gluten-free diet (GFD), seventy-one relatives of CD patients on normal diet and sixty-nine relatives on GFD were tested for several proteolytic activities, cultivable bacteria involved in gluten metabolism, SCFA and the amount of gluten in faeces. We detected faecal peptidasic activity against the gluten-derived peptide 33-mer. CD patients showed differences in faecal glutenasic activity (FGA), faecal tryptic activity (FTA), SCFA and faecal gluten content with respect to healthy volunteers. Alterations in specific bacterial groups metabolising gluten such as Clostridium or Lactobacillus were reported in CD patients. Relatives showed similar parameters to CD patients (SCFA) and healthy volunteers (FTA and FGA). Our data support the fact that commensal microbial activity is an important factor in the metabolism of gluten proteins and that this activity is altered in CD patients.

Mechanisms of the effects of probiotics on symbiotic digestion

The published data and our own data on the mechanisms of the influence of microbial probiotics, prebiotics, and their combinations on the processes of symbiotic digestion have been considered and generalized. It is shown that the effects on an organism are associated with the enhanced metabolic activity of intestinal bacteria: stimulation of bacterial fermentation of carbohydrates and formation of short-chained fatty acids, an increase in the blotting capacity of the intestines due to elongation of villi and deepening of crypts, and a decrease in secretion of toxic proteolytic products (ammonia, phenols, thiols, indoles, etc.). It has been shown that a combination of probiotics and prebiotic enhances the biological efficiency of a complex preparation, which contributes to activation of carbohydrate, protein, and mineral metabolism.

Effects of broad-spectrum antibiotics on the metabolism and pharmacokinetics of ginsenoside Rb1: A study on rats׳ gut microflora influenced by lincomycin

Ginsenoside Rb1 is a biologically active compound that is abundant in ginseng (Panax ginseng). It has been reported that ginsenosides could be metabolized by enzymes and bacteria in the large intestine. In this study, the effects of intestinal bacteria on the metabolism and pharmacokinetics of ginsenoside Rb1 were investigated using lincomycin-treated rat models (4.8g/kg and 0.12g/kg). Specifically, ginsenoside Rb1 was incubated anaerobically with rat fecal suspensions obtained from the control and two model groups at 0, 6, 12, 24, and 48h. Ginsenoside Rb1 and its metabolites were determined by HPLC analysis. Compared with the normal rats case where Rd and compound K were detected in the incubation mixture, ginsenoside Rd and F2 were found in the 0.12g/kg group, but only Rd was found in the 4.8g/kg group. Moreover, fecal β-glucosidase activity was significantly lower in lincomycin-treated (0.12g/kg and 4.8g/kg) model rats. After administration of Rb1 to rats, ginsenoside Rb1 and its metabolites Rd, Rg3, and Rh2 were detectable in normal rat urine, whereas none was detected in the two model groups. The plasma concentration-time Rb1 were compared between model groups and normal rats. The systemic exposure as evidenced by the AUC and T1/2 values was significantly higher in model groups than in normal rats. Our findings demonstrated that consumption of lincomycin could lead to the formation of specific metabolites and pharmacokinetic changes of ginsenoside Rb1 in the gut, attributed to alterations in metabolic activities of intestinal bacteria. Our results also suggested that patients who want to use intestinal bacteria-metabolized drugs such as ginseng (Panax ginseng) should pay attention to the profile of intestinal bacteria or potential drug interactions to ensure therapeutic efficacy.

Introduction to metabolic activities of intestinal bacteria

Introduction to metabolic activities of intestinal bacteria

Fecal flora of volunteers on controlled diets ,

Ten volunteers completed a 4-month diet series consisting of a control diet, a meatless diet, a high-beef diet, and the same control diet, each lasting 1 month. Fat and fiber contents were essentially the same in all four diets, but protein content was doubled during the high-beef diet. High-beef protein consumption had little effect on the composition of the intestinal flora of the volunteers. There were no significant differences between the high-beef and meatless diets in total numbers of anaerobic, facultative, or aerobic organisms isolated, nor were there major differences in the counts of the individual genera and species of bacteria encountered. The data indicate that animal protein consumption has little effect on the fecal bacterial profile in humans. The possible influence of animal fat consumption on the metabolic activities of intestinal bacteria is discussed.

Intestinal bacteria and the hydrolysis of glycosidic bonds.

SUMMARY As part of a study of the metabolic activities of intestinal bacteria, the activity of the principal glycosidases produced by the major groups of intestinal bacteria has been estimated. The results are discussed in terms of the toxicological and pharmacological effects of various ingested glycosides and of the enterohepatic circulation of compounds by four laboratory animal species commonly used in toxicological studies.

INEFFECTIVE NEOMYCIN THERAPY OF SCHIZOPHRENIA--OBSERVATIONS ON URINARY INDOLES.

The possibility that absorption of indolic or other "toxic metabolites" of intestinal bacteria may play a role in the pathogenesis of mental illness has been considered and denied off and on for over 50 years.¹Some support for further exploration of this possibility is afforded by the marked improvement in psychiatric symptoms of patients with severe liver failure associated with oral administration of neomycin²or "exclusion" of the colon.³As far as we are aware there are no reports of the effect on the symptoms of schizophrenia of decreasing the metabolic activity of intestinal bacteria with oral antibiotics. This paper reports the lack of symptomatic improvement in relapsed and chronic male schizophrenics during neomycin and phthalylsulfathiazole therapy, as well as observations on the urinary excretion of indoleacetic acid and other indoles before and during antibiotic therapy. Methods Seven male patients (aged